Contact Information
Company Information
Annual Revenue
15000000.0
Total Funding
324071006.0
Technologies
Outlook
Microsoft Office 365
Linkedin Marketing Solutions
Google Font API
Nginx
Google Tag Manager
Google Analytics
Mobile Friendly
Twitter Advertising
Keywords
biotechnology research
immunotherapy
cancer treatments
cell therapies
antibody-drug conjugates
clinical trials
biotechnology
oncology pipeline
il-15 technology
superagonist
adc technology
research & development
strategic licensing
therapeutic assets
preclinical development
commercialization
clinical development
biologics
small molecules
differentiated drugs
pipeline programs
cancer immunotherapy
tumor microenvironment
immune cells
cancer patient outcomes
boxer technology
immunocytokines
nbe-therapeutics
car t therapies
partnerships
global collaborations
data on adcs
novel therapies
solid tumors
clinical study
research laboratories
advanced clinical stages
market access
preclinical candidates
investments
m&a
drug efficacy
broad therapeutic window
targeted delivery
regulatory approvals
laboratory research
cancer drug r&d
improving efficacy
scientific innovation
cancer treatment
adcs
car t therapy
clinical-stage development
oncology market
innovative therapies
patient outcomes
research collaborations
global presence
strategic partnerships
drug development pipeline
preclinical research
therapeutic oncology assets
precision medicine
bispecific antibodies
cytokine agonists
engineered t cells
unmet medical needs
therapeutic innovations
patient-centric approach
advanced cancer therapies
international collaborations
biotechnology industry
pharmaceutical industry
health care
health
wellness & fitness
hospital & health care
mergers & acquisitions
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans